(1)
Bunick, C.; Bhatia, N.; Del Rosso, J.; Draelos, Z.; Eichenfield, L.; Kircik, L.; Lebwohl, M.; Gooderham, M.; Green, L.; Hebert, A.; Vender, R.; Zirwas, M.; Simpson, E.; Stein Gold, L.; Seal, M.; Snyder, S.; Osborne, D.; Burnett, P.; Higham, R.; Chu, D.; Berk, D. Investigator- and Patient-Rated Local Tolerability in Phase 3 Trials of Topical Roflumilast in Patients With Psoriasis, Seborrheic Dermatitis, and Atopic Dermatitis. J of Skin 2024, 8, s309.